These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 27477904)

  • 1. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
    Pritt NM; Norris AH; Berlan ED
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatricians' Attitudes and Beliefs about Long-Acting Reversible Contraceptives Influence Counseling.
    Berlan ED; Pritt NM; Norris AH
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):47-52. PubMed ID: 27639750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Qualitative Study of Factors That Influence Contraceptive Choice among Adolescent School-Based Health Center Patients.
    Hoopes AJ; Gilmore K; Cady J; Akers AY; Ahrens KR
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):259-64. PubMed ID: 26477942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to Health Care Providers' Provision of Long-Acting Reversible Contraception to Adolescent and Nulliparous Young Women.
    Hopkins B
    Nurs Womens Health; 2017; 21(2):122-128. PubMed ID: 28388997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdependent Barriers to Providing Adolescents with Long-Acting Reversible Contraception: Qualitative Insights from Providers.
    Murphy MK; Stoffel C; Nolan M; Haider S
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):436-442. PubMed ID: 26851537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
    Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
    Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
    Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2012 Oct; 120(4):983-8. PubMed ID: 22996129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
    Coates C; Gordon CM; Simpson T
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let's talk about sex (again): advancing the conversation around long-acting reversible contraception for teenagers.
    Satterwhite CL; Ramaswamy M
    Womens Health (Lond); 2015 Nov; 11(6):841-50. PubMed ID: 26626398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LARCs as first-line contraception - What can general practitioners advise young women?
    Temple-Smith M; Sanci L
    Aust Fam Physician; 2017 Oct; 46(10):710-715. PubMed ID: 29036768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
    Lotke PS
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol; 2018 May; 131(5):e130-e139. PubMed ID: 29683910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Latest in Teen Pregnancy Prevention: Long-Acting Reversible Contraception.
    McClellan K; Temples H; Miller L
    J Pediatr Health Care; 2018; 32(5):e91-e97. PubMed ID: 30180941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
    Pickle S; Wu J; Burbank-Schmitt E
    Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.